Exploring Relational Autonomy of Vietnamese Patients' Experiences in Decision-Making Regarding Hematopoietic Stem Cell Transplantation: A Qualitative Interview Study
- PMID: 40437648
- DOI: 10.1002/pon.70185
Exploring Relational Autonomy of Vietnamese Patients' Experiences in Decision-Making Regarding Hematopoietic Stem Cell Transplantation: A Qualitative Interview Study
Abstract
Background: Hematopoietic stem cell transplantation (HSCT) decisions for patients with hematologic malignancies are deeply intertwined with trust, doctor-patient communication, and interaction with family. Relational autonomy highlights how social relationships and cultural contexts influence patients' decisions, offering a crucial lens to understand this complex process.
Aims: To understand the decision-making experience of adult patients with hematologic malignancies in Vietnam regarding HSCT through the lens of relational autonomy.
Methods: Convenient and snowball sampling interviewed 22 adult patients diagnosed with hematologic malignancies who had accepted or refused HSCT. Online semi-structured interviews were conducted in Vietnam. Content analysis was applied to identify themes.
Results: Three themes emerged: "coming to identify as a patient," "experiencing the influence of relational networks," and "hoping one's voice will be heard." Trust and communication with healthcare professionals, relationships with family members, and broader social networks were found to critically shape the decision-making process. Patients initiated their consideration of HSCT within a Vietnamese cultural framework while integrating external influences. Social networks profoundly affect patient autonomy, as patients continuously reflected on their views and engaged with others to maintain their final say in decisions. Participants' interpretation of their significant other's experiences supported and maintained their autonomy.
Conclusions: The HSCT decision-making process is shaped by the interplay of patients' personal experiences, trust, socio-cultural relationships, and surrounding support systems. Relational autonomy offers key insights into how patients use social networks and cultural backgrounds to navigate their treatment choices, emphasizing the importance of supportive environments that empower patients to make informed and autonomous decisions.
Keywords: HSCT; blood cancer; doctor‐patient communication; hematologic malignancies; hematopoietic stem cell transplantation; oncology decision‐making; relational autonomy; trust.
© 2025 John Wiley & Sons Ltd.
Similar articles
-
"Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy.Health Expect. 2018 Dec;21(6):981-989. doi: 10.1111/hex.12691. Epub 2018 Apr 14. Health Expect. 2018. PMID: 29655265 Free PMC article.
-
Relational autonomy in breast diseases care: a qualitative study of contextual and social conditions of patients' capacity for decision-making.BMC Health Serv Res. 2018 Oct 25;18(1):818. doi: 10.1186/s12913-018-3622-8. BMC Health Serv Res. 2018. PMID: 30359251 Free PMC article.
-
Shared decision-making about autologous stem cell transplantation: A qualitative study of older patients and physicians.J Am Geriatr Soc. 2025 Feb;73(2):458-469. doi: 10.1111/jgs.19276. Epub 2024 Nov 22. J Am Geriatr Soc. 2025. PMID: 39575972
-
Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.Support Care Cancer. 2015 Apr;23(4):1169-96. doi: 10.1007/s00520-014-2581-9. Epub 2015 Jan 17. Support Care Cancer. 2015. PMID: 25591627 Review.
-
Importance of meaning-making for patients undergoing hematopoietic stem cell transplantation.Oncol Nurs Forum. 2014 Mar 1;41(2):E172-84. doi: 10.1188/14.ONF.E172-E184. Oncol Nurs Forum. 2014. PMID: 24578083 Review.
References
-
- K. Khaddour, C. K. Hana, and P. Mewawalla, “Hematopoietic Stem Cell Transplantation,” in StatPearls (StatPearls Publishing, 2024).
-
- J. Loke, R. Buka, and C. Craddock, “Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?,” Frontiers in Immunology 12 (2021): 659595: 2021/05/21, https://doi.org/10.3389/fimmu.2021.659595.
-
- S. Devarakonda, Y. Efebera, and N. Sharma, “Role of Stem Cell Transplantation in Multiple Myeloma,” Cancers (Basel) 13, no. 4 (2021): 863: 21/03/07, https://doi.org/10.3390/cancers13040863.
-
- T. Badar, M. R. Litzow, R. M. Shallis, et al., “Multicenter Analysis of Treatment and Outcomes for Patient With TP53 Mutated AML in the Era of Novel Therapies; Significant Impact of Allogeneic Stem Cell Transplantation on Survival,” Blood 138, no. Supplement 1 (2021): 797, https://doi.org/10.1182/blood‐2021‐147639.
-
- C. F. C. Jordens, K. Montgomery, and R. Forsyth, “Trouble in the Gap: A Bioethical and Sociological Analysis of Informed Consent for High‐Risk Medical Procedures,” Journal of bioethical inquiry 10, no. 1 (2013): 67–77, https://doi.org/10.1007/s11673‐012‐9414‐7.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources